Loading...

Akero Therapeutics, Inc.

AKRONASDAQ
Healthcare
Biotechnology
$50.56
$0.05(0.10%)

Akero Therapeutics, Inc. (AKRO) Financial Performance & Income Statement Overview

Review Akero Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
0.00%
Operating Income Growth
-65.11%
65.11%
Net Income Growth
-66.09%
66.09%
Operating Cash Flow Growth
-58.29%
58.29%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-31.98%
31.98%
ROIC
-27.51%
27.51%

Akero Therapeutics, Inc. (AKRO) Income Statement & Financial Overview

Review Akero Therapeutics, Inc.'s (AKRO) income statement with detailed quarterly and annual figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$0.00$0.00$1000.00$1000.00
Gross Profit$0.00$0.00-$1000.00-$1000.00
Gross Profit Ratio$0.00
R&D Expenses$69.29M$72.23M$55.32M$50.65M
SG&A Expenses$8.73M$9.47M$10.42M$9.30M
Operating Expenses$78.03M$81.70M$65.74M$59.95M
Total Costs & Expenses$78.03M$81.70M$65.74M$59.95M
Interest Income$9.20M$10.24M$10.98M$7.60M
Interest Expense$1.20M$1.25M$1.23M$991000.00
Depreciation & Amortization$15000.00$1000.00$1000.00$1000.00
EBITDA-$68.81M-$71.46M-$54.76M-$52.35M
EBITDA Ratio
Operating Income-$78.03M-$81.70M-$65.74M-$59.95M
Operating Income Ratio
Other Income/Expenses (Net)$8.001M$9.00M$9.75M$6.61M
Income Before Tax-$70.02M-$72.70M-$55.99M-$53.34M
Income Before Tax Ratio
Income Tax Expense$0.00$0.00$0.00-$42276.00
Net Income-$70.02M-$72.70M-$55.99M-$53.34M
Net Income Ratio
EPS-$0.99-$1.05-$0.81-$0.90
Diluted EPS-$0.99-$1.05-$0.81-$0.90
Weighted Avg Shares Outstanding$70.57M$69.44M$69.16M$59.31M
Weighted Avg Shares Outstanding (Diluted)$70.57M$69.44M$69.16M$59.31M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;